Thinking Machines Lab

Because it priced pedigree before product: US$2B at a US$12B post-money — roughly 4x any previous seed — for a five-month-old lab with nothing shipped, built around Mira Murati, John Schulman and other OpenAI alumni. The January 2026 collapse of the US$50B follow-on is the control experiment: when cohesion wobbled, expectations reset toward US$12B, showing how much of the price was the people.

Flying a flag: Albania invested ~US$10M — about 0.08% at the US$12B valuation — a stake small enough to require a budget amendment in Tirana. It previews the sovereign-money pattern across the set: the UK's Sovereign AI Fund in Ineffable's seed, Temasek in AMI Labs', Saudi HUMAIN's US$3B in xAI's Series E — states buying frontier-lab exposure as policy, at symbolically sized tickets.

Because the product lagged the price: by January 2026 the NYT reported co-founders pressing for a sale or merger over direction and release pace, followed by departures including CTO Barret Zoph. Expectations reset toward ~US$12B — a year of churn without a step-up. The counter-move is Inkling, the July 2026 open-weight family (975B and 41B parameters), shipped ahead of the reported US$5–6B raise.

Opposite structures: SSI's charter bans commercialization outright, while Thinking Machines shipped Tinker in late 2025 and the open-weight Inkling family by July 2026, leaning on operational revenue after the US$50B round fell apart. SSI's US$32B came with no product plan; TML's US$12B seed demands one — the pending round will price whether OpenAI pedigree alone still clears frontier multiples.

Because chipmakers seed future GPU buyers: NVIDIA, AMD, Cisco and ServiceNow joined a16z and Jane Street — the same strategic pattern as SSI's round and AMI Labs' five-co-lead group. The hedge cuts both ways: after the US$50B collapse, NVIDIA's reported ~US$2.5B consideration in the pending round shows hardware capital keeping its option open on a lab whose first seed it already priced.